Persistence of Anti-HB Antibodies in Healthcare Trainees: The Impact of Childhood Versus Adolescent Vaccination
Abstract
:1. Introduction
2. Materials and Methods
2.1. Sample
2.2. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Morais, L.Q.; Motta-Castro, A.R.C.; Frota, O.P.; Contrera, L.; Carvalho, P.R.T.; Fernandes, F.R.P. Hepatite B em profissionais de enfermagem: Prevalência e fatores ocupacionais de risco. Rev. Enferm. UERJ 2016, 24, e11143. [Google Scholar] [CrossRef]
- World Health Organization. Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries: Web Annex: Method for Global Reporting on Disease Burden and Service Coverage Data for Viral Hepatitis B and C; WHO Press: Geneva, Switzerland, 2024; Available online: https://www.who.int/publications/i/item/9789240091672 (accessed on 6 May 2025).
- Van Damme, P.; Ward, J.W.; Shouval, D.; Zanetti, A. Hepatiti B Vaccines. In Plotkin’s Vaccines, 7th ed.; Plotkin, S.A., Orenstein, W., Offit, P.A., Edwards, K.M., Eds.; Elsevier: Philadelphia, PA, USA, 2017. [Google Scholar]
- Chang, M.H. Hepatitis B virus infection. Semin. Fetal Neonatal Med. 2007, 12, 160–167. [Google Scholar] [CrossRef] [PubMed]
- Schillie, S.; Vellozzi, C.; Reingold, A.; Harris, A.; Haber, P.; Ward, J.W.; Nelson, N.P. Prevention of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR. Recomm. Rep. 2018, 67, 1–31. [Google Scholar] [CrossRef] [PubMed]
- Hsu, Y.C.; Huang, D.Q.; Nguyen, M.H. Global burden of hepatitis B virus: Current status, missed opportunities and a call for action. Nat. Rev. Gastroenterol. Hepatol. 2023, 20, 524–537. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017—Recommendations. Vaccine 2019, 37, 223–225. [Google Scholar] [CrossRef]
- Stroffolini, T.; Morisco, F.; Ferrigno, L.; Pontillo, G.; Iantosca, G.; Cossiga, V.; Crateri, S.; Tosti, M.E.; The Seieva Collaborating Group. Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European country. Viruses 2022, 14, 245. [Google Scholar] [CrossRef]
- Hepatitis, B.; Pattyn, V.J.; Hendrickx, G.; Vorsters, A.; Van Damme, P. Centre for the Evaluation of Vaccination. J. Infect. Dis. 2021, 224, S343–S351. [Google Scholar]
- Auta, A.; Adewuyi, E.O.; Kureh, G.T.; Onoviran, N.; Adeloye, D. Hepatitis B vaccination coverage among health-care workers in Africa: A systematic review and meta-analysis. Vaccine 2018, 36, 4851–4860. [Google Scholar] [CrossRef]
- Ministerial Decree 165 of 04/10/1991. Available online: https://www.tobaccocontrollaws.org/legislation/italy/laws (accessed on 6 May 2025).
- Prüss-Üstün, A.; Rapiti, E.; Hutin, Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am. J. Ind. Med. 2005, 48, 482–490. [Google Scholar] [CrossRef]
- La Rotta, E.I.G.; Garcia, C.S.; Pertuz, C.M.; Miquilin, I.O.C.; Camisao, A.R.; Trevisan, D.D.; Aoki, F.H.; Correa-Filho, H.R. Conhecimento e adesão como fatores associados a acidentes com agulhas contaminadas com material biológico: Brasil e Colômbia. Cienc. Saude Colet. 2020, 25, 715–727. [Google Scholar] [CrossRef] [PubMed]
- Coppeta, L.; Pompei, A.; Balbi, O.; Zordo, L.M.; Mormone, F.; Policardo, S.; Lieto, P.; Pietroiusti, A.; Magrini, A. Persistence of Immunity for Hepatitis B Virus among Heathcare Workers and Italian Medical Students 20 Years after Vaccination. Int. J. Environ. Res. Public Health 2019, 16, 1515. [Google Scholar] [CrossRef] [PubMed]
- Jack, A.D.; Hall, A.J.; Maine, N.; Mendy, M.; Whittle, H.C. What level of hepatitis B antibody is protective? J. Infect. Dis. 1999, 179, 489–492. [Google Scholar] [CrossRef] [PubMed]
- Propst, T.; Propst, A.; Lhotta, K.; Vogel, W.; König, P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am. J. Kidney Dis. 1998, 32, 1041–1045. [Google Scholar] [CrossRef]
- Wiström, J.; Ahlm, C.; Lundberg, S.; Settergren, B.; Tärnvik, A. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine 1999, 17, 2162–2165. [Google Scholar] [CrossRef]
- Bruce, M.G.; Bruden, D.; Hurlburt, D.; Zanis, C.; Thompson, G.; Rea, L.; Toomey, M.; Townshend-Bulson, L.; Rudolph, K.; Bulkow, L.; et al. Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose. J. Infect. Dis. 2016, 214, 16–22, Erratum in J. Infect. Dis. 2024, 230, e504. [Google Scholar] [CrossRef] [PubMed]
- Simons, B.C.; Spradling, P.R.; Bruden, D.J.; Zanis, C.; Case, S.; Choromanski, T.L.; Apodaca, M.; Brogdon, H.D.; Dwyer, G.; Snowball, M.; et al. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen. J. Infect. Dis. 2016, 214, 273–280. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Chang, Y.C.; Wang, J.H.; Chen, Y.S.; Lin, J.S.; Cheng, C.F.; Chu, C.H. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: A cross-sectional school-based study. BMC Public Health 2014, 14, 991. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC). Immunization of health-care personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2011, 60, 1–45. [Google Scholar] [PubMed]
- Trabucco Aurilio, M.; Mennini, F.S.; Ferrari, C.; Somma, G.; Di Giampaolo, L.; Bolcato, M.; De-Giorgio, F.; Muscatello, R.; Magrini, A.; Coppeta, L. Main Predictors of COVID-19 Vaccination Uptake among Italian Healthcare Workers in Relation to Variable Degrees of Hesitancy: Result from a cross-sectional online survey. Trop. Med. Infect. Dis. 2022, 7, 419. [Google Scholar] [CrossRef]
- Baghianimoghadam, M.H.; Shadkam, M.N.; Hadinedoushan, H. Immunity to hepatitis B vaccine among health care workers. Vaccine 2011, 29, 2727–2729. [Google Scholar] [CrossRef]
- Osiowy, C. From infancy and beyond… ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity. Hum. Vaccines Immunother. 2018, 14, 2093–2097. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Di Giampaolo, L.; Costantini, E.; Di Nicola, M.; Porreca, A.; D’amore, G.; Coppeta, L.; Mangifesta, R. Titer of anti-HBs in health professions trainees: Prevalence of antibody coverage in a University of Central Italy. Hum. Vaccines Immunother. 2022, 18, 1886805. [Google Scholar] [CrossRef] [PubMed]
- Aurilio, M.T.; Iannuzzi, I.; Di Giampaolo, L.; Pietroiusti, A.; Ferrari, C.; Coppeta, L. Cross-sectional Serological Study for Measles among Italian Medical Students in 2020. Open Public Health J. 2020, 13, 692–695. [Google Scholar]
- Floreani, A.; Baldo, V.; Cristofoletti, M.; Renzulli, G.; Valeri, A.; Zanetti, C.; Trivello, R. Long-term persistence of anti-HBs after vaccination against HBV: An 18 year experience in health care workers. Vaccine 2004, 22, 607–610. [Google Scholar] [CrossRef]
- Coppeta, L.; Ferrari, C.; Verno, G.; Somma, G.; Trabucco Aurilio, M.; Di Giampaolo, L.; Treglia, M.; Magrini, A.; Pietroiusti, A.; Rizza, S. Protective Anti-HBs Antibodies and Response to a Booster Dose in Medical Students Vaccinated at Childhood. Vaccines 2023, 11, 1326. [Google Scholar] [CrossRef]
- Saffar, M.J.; Rezai, M.S. Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth. Indian Pediatr. 2004, 4, 1232–1237. [Google Scholar]
- Van Herck, K.; Van Damme, P. The Immunological Basis for Immunization Series—Module 22: Hepatitis B. Available online: https://apps.who.int/iris/bitstream/handle/10665/77755/9789241504751_eng.pdf;jsessionid=72E624435FD359D0654C8F6F6706E2AC?sequence=1.18 (accessed on 6 May 2025).
- Centers for Disease Control and Prevention. Protection Against Viral Hepatitis Recommendations of the Immunization Practices Advisory Committee (ACIP); Recommendations and Reports; Centers for Disease Control and Prevention: Atlanta, GA, USA, 1990; Volume 39, pp. 1–26. [Google Scholar]
- Poorolajal, J.; Hooshmand, E. Booster dose vaccination for preventing hepatitis B. Cochrane Database Syst. Rev. 2016, 2016, CD008256. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ferrari, C.; Somma, G.; Olesen, O.; Buonomo, E.; Pasanisi Zingarello, M.; Mazza, A.; Rizza, S.; Di Giampaolo, L.; Magrini, A.; Ponzani, F.; et al. Measles vaccine uptake among Italian medical students compared to the pre-COVID-19 era. Hum. Vaccines Immunother. 2023, 19, 2252681. [Google Scholar] [CrossRef]
- Signorelli, C.; Oleari, F.; Greco, D.; Ruocco, G.; Guerra, R.; Rezza, G.; Vaia, F.; Campitiello, M.R.; Fara, G.M. The Italian National Vaccine Prevention Plans, 1999/2020–2023/2025: Challenges and obstacles to vaccine coverage goals. Comment. Ann. Ist. Super. Sanita 2024, 60, 247–251. [Google Scholar] [CrossRef] [PubMed]
Gender, n (%) | |
---|---|
F | 1296 (63.9%) |
M | 732 (36.1%) |
Age, years | 25.89 ± 6.10 |
Vaccination period, n (%) | |
Pediatric age (PED) | 1754 (86.5%) |
Adolescence (ADO) | 274 (13.5%) |
HBsAb, n (%) | |
Non-Protective titer (<10 IU/L) | 1029 (50.7%) |
Protective titer (≥10 IU/L) | 999 (49.3%) |
ADO (n = 274) | PED (n = 1754) | p-Value * | |
---|---|---|---|
Gender, n (%) | |||
F | 170 (62.0%) | 1126 (62.2%) | 0.490 |
M | 104 (38.0%) | 628 (35.8%) | |
Age, years | 37.85 ± 5.15 | 24.03 ± 3.63 | <0.001 |
HbsAb, n (%) | |||
Non-Protective titer (<10 IU/L) | 57 (20.8%) | 972 (55.4%) | <0.001 |
Protective titer (≥10 IU/L) | 217 (79.2%) | 782 (44.6%) |
ADO (n = 274) | PED (n = 1754) | |||||
---|---|---|---|---|---|---|
Females (n = 170) | Males (n = 104) | p-Value | Females (n = 1126) | Males (n = 628) | p-Value * | |
Age, years | 38.20 ± 4.91 | 37.27 ± 4.49 | 0.151 | 23.87 ± 3.67 | 24.31 ± 3.53 | 0.013 |
HbsAb, n (%) | ||||||
Non-Protective titer (<10 IU/L) | 35 (20.59%) | 22 (21.15%) | 0.911 | 637 (56.57%) | 335 (53.34%) | 0.192 |
Protective titer (≥10 IU/L) | 135 (79.41%) | 82 (78.85%) | 489 (43.43%) | 293 (46.66%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Di Giampaolo, L.; Coppeta, L.; Borrelli, P.; Astolfi, P.; Resta, A.; Loffredo, L.; Di Menno Di Bucchianico, F.; Mangifesta, R.; Ippoliti, L.; Ferrari, C. Persistence of Anti-HB Antibodies in Healthcare Trainees: The Impact of Childhood Versus Adolescent Vaccination. Vaccines 2025, 13, 562. https://doi.org/10.3390/vaccines13060562
Di Giampaolo L, Coppeta L, Borrelli P, Astolfi P, Resta A, Loffredo L, Di Menno Di Bucchianico F, Mangifesta R, Ippoliti L, Ferrari C. Persistence of Anti-HB Antibodies in Healthcare Trainees: The Impact of Childhood Versus Adolescent Vaccination. Vaccines. 2025; 13(6):562. https://doi.org/10.3390/vaccines13060562
Chicago/Turabian StyleDi Giampaolo, Luca, Luca Coppeta, Paola Borrelli, Piergiorgio Astolfi, Andrea Resta, Lucia Loffredo, Flavia Di Menno Di Bucchianico, Rocco Mangifesta, Lorenzo Ippoliti, and Cristiana Ferrari. 2025. "Persistence of Anti-HB Antibodies in Healthcare Trainees: The Impact of Childhood Versus Adolescent Vaccination" Vaccines 13, no. 6: 562. https://doi.org/10.3390/vaccines13060562
APA StyleDi Giampaolo, L., Coppeta, L., Borrelli, P., Astolfi, P., Resta, A., Loffredo, L., Di Menno Di Bucchianico, F., Mangifesta, R., Ippoliti, L., & Ferrari, C. (2025). Persistence of Anti-HB Antibodies in Healthcare Trainees: The Impact of Childhood Versus Adolescent Vaccination. Vaccines, 13(6), 562. https://doi.org/10.3390/vaccines13060562